This "public-private partnership," as Trump's "vaccine czar" Moncef Slaoui described it, allows for Chinese virus vaccine recipients in the United States to be surveilled using "incredibly precise ... tracking systems" that Slaoui says will "ensure that patients each get two doses of the same vaccine and to monitor them for adverse health effects."
Both Google and Oracle were contracted to manage this "tracking system," though Slaoui did not specify their precise roles beyond helping to "collect and track vaccine data."
One day before The Wall Street Journal published a story about this, The New York Times published one of its own, calling the technology a "very active pharmacovigilance surveillance system." This is what Slaoui called it about a month prior during an interview with the journal Science, though he apparently left out the word "surveillance."
Still, the surveillance component was implied, and Slaoui further clarified that the purpose of the system is to "make sure that when the vaccines are introduced that we'll absolutely continue to assess their safety."
Later on, Slaoui himself started using the words "tracking" and "surveillance" to describe the program. Perhaps it was clear at that point that Americans were not at all concerned, or were perhaps too engrossed in the 2020 election drama to even know what was happening.
Many Trump supporters were too busy defending their mascot at the time to notice what the president's OWS scheme entailed. Two official OWS documents released in mid-September reveal a plan so Orwellian that had Barack Obama presented it, the conservative right would have skewered him as a tyrant.
Because it was Trump pushing his "great" vaccines to the public, OWS got a free pass – even though very few people had any idea about its full ramifications.
The released documents show that those injected with Chinese virus vaccines would be monitored for a full 24 months after the first dose. This monitoring is to be handled by a "pharmacovigilance system," the documents explain.
Since none of the Wuhan flu vaccines being pushed by the government are officially licensed by the Food and Drug Administration (FDA), everyone who gets one is inadvertently participating in a global vaccine trial. This is openly admitted in the released documents.
According to the Department of Health and Human Services (HHS) and the Department of Defense (DoD), there is "limited previous data" concerning the "safety" of these vaccines when injected into humans. Consequently, "the long-term safety of these vaccines will be carefully assessed using pharmacovigilance surveillance and Phase 4 (post-licensure) clinical trials."
"The key objective of pharmacovigilance is to determine each vaccine's performance in real-life scenarios, to study efficacy, and to discover any infrequent and rare side effects not identified in clinical trials," the documents go on to explain.
In other words, everyone getting jabbed for Chinese germs is now a participant in a massive human clinical trial taking place all around us rather than inside a laboratory. Since the long-term adverse effects of these experimental gene therapy injections is unknown, OWS has granted Google and Oracle the privilege of surveilling all vaccine recipients as part of a long-term public trial.
You can learn more about what this mass surveillance program entails at this link.
You will also find more related news about the Orwellian implications of Trump's Operation Warp Speed program at Tyranny.news.
Sources for this article include: